Bliss GVS Pharma Ltd share price logo

Bliss GVS Pharma Ltd

NSE: BLISSGVS

BSE: 506197

Small Cap

Pharma Sector

₹647.50

-33.40

(-4.91%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Bliss GVS Pharma shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-45%

Searches for Bliss GVS Pharma on INDmoney have decreased by 45% over the last 30 days.

Average holding period of indmoney investors

12 days

INDmoney investors hold Bliss GVS Pharma shares for an average of 12 days.

Key Events for Bliss GVS Pharma

Last Dividend Declared

₹1.00 per share, declared on 12/05/2026

View Dividend History

Bliss GVS Pharma Stock Performance

as on October 30, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹646.90
    ₹670.00
    downward going graph

    0.09%

    Downside

    3.47%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹118.00
    ₹739.90
    downward going graph

    81.78%

    Downside

    14.27%

    Upside

    downward going graph

Bliss GVS Pharma share price movements today

Previous Close
₹680.90
Open
₹660.00
Volume
4.46L
Upper Circuit
₹714.90
Lower Circuit
₹646.90
Day's Low - High
₹646.90 - ₹670.00
52 Week Low - High
₹118.00 - ₹739.90

Bliss GVS Pharma Historical Returns

1 Month Return
-0.39 %
3 Month Return
+ 46.23 %
1 Year Return
+ 334.08 %
3 Year Return
+ 709.63 %
5 Year Return
+ 531.93 %

Bliss GVS Pharma Fundamentals

as on October 30, 2026 at 4:01 pm IST

Market Cap

₹6,888.36 Cr

Return on Equity (ROE)

8.75

PE Ratio (TTM)

44.74

Return on capital employed (ROCE)

12.51

Industry PE ratio

51.65

Beta (LTM)

1.11

P/B Ratio

1.97

Dividend Yield

0.46

PEG Ratio

9.28

Quarterly Earnings Growth YOY

86.57

EPS (TTM)

12.74

Book Value

112.76

Bliss GVS Pharma Stock Valuation

as on October 30, 2026 at 4:01 pm IST

Bliss GVS Pharma in the last 5 years

  • Overview

  • Trends

Lowest (7.08x)

August 22, 2019

Today (44.74x)

October 29, 2026

Industry (51.65x)

October 29, 2026

Highest (576.11x)

January 3, 2022

LowHigh

Today’s Price to Earnings Ratio: 44.74x

Bliss GVS Pharma Technical Analysis

Track how Bliss GVS Pharma technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Neutral

Overall

Bearish5
Bullish8
Neutral2

Oscillators

Name

Value

Action

MACD level (12,26)
-0.12
Bullish
CCI (20)
592.42
Bearish
RSI (14)
55.08
Neutral
Momentum (10)
1.5
Neutral
ADI (14)
32.37
Bullish
Ultimate Oscillator (7,14,28)
15.03
Bearish

Moving Averages

Name

Value

Action

SMA (20)
647.1
Bullish
EMA (20)
647.45
Bullish
VWMA (20)
647.2
Bullish
SMA (50)
647.84
Bullish
EMA (50)
647.9
Bullish
SMA (200)
651.83
Bearish
EMA (200)
650.99
Bearish
KAMA (200)
649.32
Bearish
DEMA (200)
646.48
Bullish

Bliss GVS Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bliss GVS Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Bliss GVS Pharma Ltd image
Bliss GVS Pharma Ltd
NA6,888.36106.39%0.53134927
Kilitch Drugs (India) Ltd image
Kilitch Drugs (India) Ltd
BUY703.856.04%0.6229235
Coral Laboratories Ltd image
Coral Laboratories Ltd
NA172.918.06%0.001685
Vasundhara Rasayans Ltd image
Vasundhara Rasayans Ltd
NA41.35-0.31%0.00535
Godavari Drugs Ltd image
Godavari Drugs Ltd
NA137.0817.94%0.004105
See all

Bliss GVS Pharma Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Sales
200.72
198.13
183.64
217.68
210.42
197.99
207.47
244.4
218.25
256.99
285.58
313.37
Other Income
5.42
5.6
4.12
5.04
15.27
12.07
35.45
8.46
18.46
11.19
9.6
8.3
Total Income
206.14
203.73
187.77
222.72
225.68
210.05
242.92
252.86
236.71
268.18
295.18
321.67
Expenses
157.02
198.98
149.31
176.2
180.63
176.9
166.14
200.92
185.98
212.55
209.18
232.78
Operating Profit
43.7
-0.85
34.33
41.48
29.79
21.09
41.33
43.48
32.27
44.44
76.4
80.59
Operating Profit Margin %
21.77%
-0.43%
18.69%
19.06%
14.16%
10.65%
19.92%
17.79%
14.79%
17.29%
26.75%
25.72%
Profit Before Interest, Tax and Depreciation
49.12
4.75
38.45
46.51
45.05
33.15
76.78
51.94
50.73
55.63
86
88.89
Interest
2.12
1.85
1.53
3.83
1.08
1.68
5.47
3.04
1.49
2.01
0.58
3.3
Depreciation
6.95
6.85
6.85
6.98
7.55
8.04
8.2
8.26
8.35
8.67
9.94
10.5
Profit Before Tax
40.05
-3.95
30.07
35.7
36.42
23.43
63.11
40.64
40.89
44.95
75.48
75.09
Tax Paid
10.97
0.96
7.96
10.01
10.62
6.79
18.74
12.04
16.12
7.95
24.11
21.76
Profit After Tax
29.07
-4.91
22.11
25.69
25.8
16.65
44.36
28.59
24.78
37
51.37
53.34
Total Net profit including share of profit / Loss from associate company
29.07
-4.91
22.11
25.69
25.8
16.65
44.36
28.59
24.78
37
51.37
53.34
EPS
2.64
-0.88
1.97
2.31
2.27
1.47
4.08
2.58
2.2
3.37
4.73
4.92
Actual EPS
2.64
-0.88
1.97
2.31
2.27
1.47
4.08
2.58
2.2
3.37
4.73
4.92
Adjusted EPS
2.64
-0.88
1.97
2.31
2.27
1.47
4.08
2.58
2.2
3.37
4.73
4.92
Diluted EPS
2.6
-0.86
1.93
2.29
2.27
1.46
4.04
2.54
2.14
3.28
4.65
4.81

Bliss GVS Pharma Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
814.64
898.57
689.31
577.21
747.45
751.59
770.24
809.73
927.11
Other Income
26.54
37.63
39.19
20.22
31.49
17.79
28.74
36.49
73.53
Total Income
841.18
936.2
728.49
597.43
778.95
769.37
798.98
846.22
1,000.64
Expenses
651.7
740.93
579.37
470.56
702.71
634.27
648.82
683.04
765.56
Operating Profit
162.94
157.64
109.94
106.65
44.74
117.32
121.42
126.69
161.55
Operating Profit Margin %
20%
17.54%
15.95%
18.48%
5.99%
15.61%
15.76%
15.65%
17.43%
Profit Before Interest, Tax and Depreciation
189.48
195.27
149.12
126.87
76.24
135.11
150.16
163.18
235.08
Interest
22.8
4.41
7.57
5.51
4.74
10.36
6.91
8.12
12.01
Depreciation
21.38
8.94
12.59
17.23
17.33
18.67
26.38
29.42
33.48
Profit Before Tax
145.3
181.92
128.96
104.13
54.17
106.08
116.87
125.64
189.59
Tax Paid
56.63
55.25
33.72
30.15
31.04
29.33
35.29
35.39
54.86
Profit After Tax
88.67
126.66
95.25
73.97
23.13
76.73
81.58
90.26
134.73
Total Net profit including share of profit / Loss from associate company
88.67
126.66
95.25
73.97
23.13
76.73
81.58
90.26
134.73
EPS
5.7
11.99
9.43
6.64
1.46
6.83
7.23
8.02
12.23
Actual EPS
5.7
11.99
9.43
6.64
1.46
6.83
7.23
8.02
12.23
Adjusted EPS
5.7
11.99
9.43
6.64
1.46
6.83
7.23
8.02
12.23
Diluted EPS
5.7
11.99
9.43
6.49
1.43
6.72
7.11
7.95
12

Bliss GVS Pharma Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
112.95
289.47
17.64
39.95
46.7
63.97
135.48
34.31
102.82
105.91
138.72
Cash Flow from Investing Activities
-51.55
-249.23
47.87
-78.7
-40.09
-45.37
-102.89
-6.36
-83.34
-75.49
-38.17
Cash Flow from Financing Activities
-40.25
-10.13
-75.98
16.83
-6.3
-20.79
-23.73
-24.95
-20.88
-30.2
-89.21
Net Cash Flow
22.51
30.11
-10.46
-21.91
0.3
-2.21
8.85
3.02
-1.42
0.23
11.32

Bliss GVS Pharma Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Promoters
34.97%
34.97%
34.9%
34.82%
35.1%
35.29%
35.44%
35.39%
35.36%
35.36%
35.01%
50.07%
DII
6.59%
6.59%
6.58%
6.57%
6.55%
6.55%
6.54%
5.98%
5.78%
5.04%
9.47%
9.62%
FII
0%
14.73%
13.25%
12.13%
13.51%
13.18%
12.65%
13.27%
14.54%
10.45%
8.07%
5.03%
Public
43.08%
43.71%
45.27%
46.49%
44.84%
44.98%
45.36%
45.36%
44.32%
49.15%
47.45%
35.28%
Total Outstanding Shares
10,46,90,822
10,46,90,822
10,48,82,572
10,51,44,472
10,53,66,272
10,53,70,272
10,54,97,522
10,56,49,472
10,57,88,972
10,57,88,972
10,60,56,222
10,63,30,472
Total Shareholders
40,758
45,157
44,737
52,937
49,558
49,517
46,707
44,461
43,380
44,874
46,767
47,944

Mutual Funds Buying / Exiting Bliss GVS Pharma

Holdings as of 15 Oct 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Bliss GVS Pharma

Sorted by largest increase in holding, month-over-month.

No buying activity data available right now

No buying activity data available right now

Mutual Funds Exiting Bliss GVS Pharma

Sorted by largest decrease in holding, month-over-month.

Fund Name

Value of Holding

Decrease (MoM)

Holding %

Bandhan BSE Healthcare Index Fund Direct Growth

Bandhan BSE Healthcare Index Fund Direct Growth

₹0.06 Cr

₹0.01 Cr (-9.24%)

0.29%

Bliss GVS Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Bliss GVS Pharma.

  • Bliss GVS Pharma Ltd Earnings Results

    Bliss GVS Pharma Ltd’s net profit jumped 91.74% since last year same period to ₹52.25Cr in the Q2 2026-2027. On a quarterly growth basis, Bliss GVS Pharma Ltd has generated 4.29% jump in its net profits since last 3-months.

    Read More

  • Bliss GVS Pharma Ltd Dividends May,2026

    In the quarter ending March 2026, Bliss GVS Pharma Ltd has declared dividend of ₹1.00 per share on 12 May 2026 - translating a dividend yield of 0.22%.

    Read More about Dividends

Indices Featuring Bliss GVS Pharma Stock

Check stock indices that include Bliss GVS Pharma.

BSE Healthcare

₹50,168.37

+474.08 (▲0.95%)

Insights on Bliss GVS Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, BLISSGVS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, BLISSGVS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, 23.27 Cr → 52.25 Cr (in ₹), with an average increase of 22.6% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 236.71 Cr → 321.67 Cr (in ₹), with an average increase of 9.7% per quarter

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 35.01% to 50.07% in Sep 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, BLISSGVS stock has moved up by 9.8%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 0.26% to 0.00% in Sep 2026 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 8.07% to 5.03% in Sep 2026 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 47.45% to 35.28% in Sep 2026 quarter

About Bliss GVS Pharma Ltd

Bliss GVS Pharma Ltd is an export-oriented pharmaceutical company providing products in the antimalarial, antifungal, antibacterial, anti-inflammatory, and antibiotic segments. Boasting one of the largest portfolios of Suppositories and Pessaries dosage forms, the leading company is the only EUGMP certified suppositories manufacturer in India, and has a research and development centre with over 50 scientists certified by the Department of Scientific and Industrial Research.

Bliss GVS Pharma has a successful history, with various achievements over the years, such as investment in 51 share capital of Lifeon Labs Pvt Ltd. and the formation of a new company, Asterisk Lifesciences Limited, as a wholly owned foreign subsidiary in the UK for registrations and marketing in Europe. The company has also procured a USD 111.40 million contract from Aon.

To further its growth, Bliss GVS Pharma divested three subsidiaries and one stepdown subsidiary in 2018. The company also invested in a new 200,000 sq. ft. multiproduct facility in Maharashtra, equipped with state-of-the-art process equipment and utilities. In the financial year 2019-2020, the company had 4 wholly owned subsidiaries and 3 stepdown subsidiaries.

Revenue: ₹313.37Cr as on September 2026 (Q2 FY27)
Net Profit: ₹53.34Cr as on September 2026 (Q2 FY27)
Listing date: 26 Jul, 2010
Chairperson Name: Subramanian R Vaidya
OrganisationBliss GVS Pharma Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOSubramanian R Vaidya
E-voting on sharesClick here to vote

FAQs

What is Bliss GVS Pharma share price today?

Bliss GVS Pharma share price today stands at ₹647.5 as on at the close of the market. Bliss GVS Pharma share today touched a day high of ₹670 and a low of ₹646.9.

What is the 52 week high and 52 week low range for Bliss GVS Pharma share?

Bliss GVS Pharma touched a 52 week high of ₹739.9 and a 52 week low of ₹118. Bliss GVS Pharma share price today i.e. is closed at ₹647.5, which is -12.49% down from its 52 week high and 448.73% up from its 52 week low.

What is Bliss GVS Pharma's market capitalisation today?

Bliss GVS Pharma market capitalisation is ₹6,888.36 Cr as on .

How to buy Bliss GVS Pharma shares?

To buy Bliss GVS Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for BLISSGVS or Bliss GVS Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Bliss GVS Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Bliss GVS Pharma trading volume today?

Bliss GVS Pharma trading volume is 4.46L as on . This means that 4.46L shares of Bliss GVS Pharma were bought and sold on the stock market during today's trading session.